MedTrace Logo

Everolimus- Versus Biolimus-Eluting Stents in All-Comers

NCT01472705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 814

Last updated 2015-12-03

No results posted yet for this study

Summary

This study sought to investigate safety and efficacy of biolimus-eluting stents (BES) with biodegradable polymer as compared with everolimus-eluting stents (EES) with durable polymer through 3 years of follow-up.

Conditions

Sponsors & Collaborators

  • University of Freiburg

    lead OTHER

Principal Investigators

  • Stéphane P Cook, MD · University Fribourg

  • Mario Togni, MD · University Fribourg

  • Markus Oberhänsli, MD · University Fribourg

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2010-11-30
Completion
2011-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01472705 on ClinicalTrials.gov